Original language | English (US) |
---|---|
Pages (from-to) | 1762-1766 |
Number of pages | 5 |
Journal | Morbidity and Mortality Weekly Report |
Volume | 69 |
Issue number | 47 |
DOIs | |
State | Published - Nov 2020 |
Externally published | Yes |
ASJC Scopus subject areas
- Health(social science)
- Health Information Management
- Health, Toxicology and Mutagenesis
- Epidemiology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Morbidity and Mortality Weekly Report, Vol. 69, No. 47, 11.2020, p. 1762-1766.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Decline in SARS-CoV-2 antibodies after mild infection among frontline health care personnel in a multistate hospital network - 12 States, April-August 2020
AU - CDC COVID-19 Response Team
AU - IVY Network
AU - Self, Wesley H.
AU - Tenforde, Mark W.
AU - Stubblefield, William B.
AU - Feldstein, Leora R.
AU - Steingrub, Jay S.
AU - Shapiro, Nathan I.
AU - Ginde, Adit A.
AU - Prekker, Matthew E.
AU - Brown, Samuel M.
AU - Peltan, Ithan D.
AU - Gong, Michelle N.
AU - Aboodi, Michael S.
AU - Khan, Akram
AU - Exline, Matthew C.
AU - Clark Files, D.
AU - Gibbs, Kevin W.
AU - Lindsell, Christopher J.
AU - Rice, Todd W.
AU - Jones, Ian D.
AU - Halasa, Natasha
AU - Keipp Talbot, H.
AU - Grijalva, Carlos G.
AU - Casey, Jonathan D.
AU - Hager, David N.
AU - Qadir, Nida
AU - Henning, Daniel J.
AU - Coughlin, Melissa M.
AU - Schiffer, Jarad
AU - Semenova, Vera
AU - Li, Han
AU - Thornburg, Natalie J.
AU - Patel, Manish M.
N1 - Funding Information: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Christopher J. Lindsell reports grants from National Institutes of Health, grants from Department of Defense, Marcus Foundation, Endpoint Health, Entegrion, bioMerieux, and Bioscape Digital, outside the submitted work. Daniel J. Henning reports personal fees from CytoVale and grants from Baxter, outside the submitted work. Akram Khan reports grants from United Therapeutics, Actelion Pharmaceuticals, Regeneron, and Reata Pharmaceuticals, outside the submitted work. Samuel M. Brown reports grants from National Institutes of Health, Department of Defense, Intermountain Research and Medical Foundation, and Janssen; consulting fees paid to his employer from Faron and Sedana, all outside the submitted work. Ithan D. Peltan reports grants from the National Institutes of Health and, outside the submitted work, grants from Asahi Kasei Pharma, Immunexpress Inc., Janssen Pharmaceuticals, and Regeneron. Carlos Grijalva reports other from Pfizer, other from Merck, other from Sanofi-Pasteur, grants from Campbell Alliance, the National Institutes of Health, the Food and Drug Administration, the Agency for Health Care Research and Quality, outside the submitted work. Todd W. Rice reports consulting work for Cumberland Pharmaceuticals, Inc, outside the submitted work. H. Keipp Talbot has served on a data safety and monitoring board for Seqirus. Natasha Halasa receives grant support from Quidel and Sanofi, donation of vaccines and hemagglutination inhibition/ microneutralization titers performed by Sanofi, and speaker fees by an educational grant supported by Genentech, outside the submitted work. No other potential conflicts of interest were disclosed.
PY - 2020/11
Y1 - 2020/11
UR - http://www.scopus.com/inward/record.url?scp=85096816835&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096816835&partnerID=8YFLogxK
U2 - 10.15585/MMWR.MM6947A2
DO - 10.15585/MMWR.MM6947A2
M3 - Article
C2 - 33237893
AN - SCOPUS:85096816835
SN - 0149-2195
VL - 69
SP - 1762
EP - 1766
JO - Morbidity and Mortality Weekly Report
JF - Morbidity and Mortality Weekly Report
IS - 47
ER -